Description
A prodrug of the NSAID amfenac; metabolized to amfenac following topical exposure to ex vivo rabbit cornea; inhibits PG synthase 1 (IC50 = 64.3 µM); inhibits PG synthesis ex vivo in isolated rabbit iris/ciliary body by 59.9-100% at a topical ocular dose of 50 µL of a 0.1% solution; reduces protein and PGE2 accumulation in a rabbit model of acute ocular inflammation when used topically at a concentration of 0.1% prior to paracentesis
Formal name: 2-amino-3-benzoyl-benzeneacetamide
Synonyms: AHR 9434|AL 6515
Molecular weight: 254.3
CAS: 78281-72-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Cyclooxygenases||Product Type|Biochemicals|Small Molecule Inhibitors|Prostaglandin Synthases||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway||Research Area|Neuroscience|Ophthalmology||Research Area|Neuroscience|Pain Research